Cheap-to-serve incremental business: management says the next tranche of volume costs it almost nothing extra
The model's full reasoning — Q3 2021 call → NOWe need to determine if management conveys that the cost of serving the next increment of business is unusually low because resources are already built and paid for, and that additional business is already arriving. From the transcript, management discusses pre-commercialization for vadadustat. They have an existing commercial footprint with Auryxia. They mention that they have a nephrology-focused sales force already in place, and that they can leverage existing infrastructure. For example, John Butler says: "We have an experienced team that knows the payers, healthcare providers, and patients." Dell Faulkingham says: "We have an experienced nephrology focused field team... we really feel like we've largely have the team here at Akebia to launch in dialysis." Also, they mention that they have a distribution relationship with Vifor that gives access to Fresenius, etc. They also mention that they have supply chain in place with redundancy. They say they are "deep in commercial preparedness activities" and that they have "a robust launch plan." They also mention that they have "already existing commercial footprint" and that they can avoid "more significant supply chain build out costs than most other biotechs without a commercial products would incur." So they are saying that the infrastructure is already there. Now, is additional business arriving? They talk about Auryxia revenue growing. They say "Revenue for Auryxia continues to grow." They also talk about vadadustat launch preparation, but that's not yet approved. However, they mention that they are preparing for launch, but the business is not yet arriving for vadadustat. For Auryxia, they say revenue is growing. They also mention that they expect Auryxia to deliver annual revenue growth for 2021. So there is growth in Auryxia. But is that growth riding on an already-built base? Yes, they have the sales force and infrastructure for Auryxia. They also mention that they will use the same team for vadadustat launch. So the incremental business from vadadustat will be served by the same team, but vadadustat is not yet approved, so that business is not arriving yet. However, they are preparing for it. The question asks: "additional business of exactly that kind is ALREADY ARRIVING NOW?" For vadadustat, it's not yet approved, so no.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| TGLS | Tecnoglass Inc. | Q2 2023 | 2023-08-08 | A |
| ADPT | Adaptive Biotechnologies Corporation | Q4 2022 | 2023-02-14 | C+ |
| SIBN | SI-BONE, Inc. | Q3 2022 | 2022-11-07 | C+ |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| HFWA | Heritage Financial Corporation | Q4 2021 | 2022-01-27 | A |
| AMC | AMC Entertainment Holdings, Inc. | Q2 2021 | 2021-08-09 | D |
| ESRT | Empire State Realty Trust, Inc. | Q2 2021 | 2021-07-29 | C+ |
| UMH | UMH Properties, Inc. | Q3 2018 | 2018-11-02 | C+ |
| WES | Western Midstream Partners, LP | Q3 2018 | 2018-10-31 | D |
| SATS | EchoStar Corporation | Q1 2018 | 2018-05-10 | C+ |
| ATI | Allegheny Technologies Incorporated | Q1 2018 | 2018-04-24 | B |
SATS · Q1 2018 → YESThe question is about whether management conveys that the cost of serving the next increment of business has become unusually low, meaning additional volume can be delivered with already built and pai...NO The transcript shows management describing high growth with significant upfront acquisition costs, fixed costs leading to margin expansion as growth slows, and beams filling up faster than expected on Jupiter-2 (implying approaching capacity limits rather than excess capacity). However, there is no clear indication of an already-built, underutilized base where additional business is arriving on resources already paid for without new capacity investment. Instead, they highlight ongoing build-out (Jupiter-3 in 2021) and potential slowdowns, which aligns with the "NO" criteria for being near limits or in a growth cycle requiring new spending.
ATI · Q1 2018 → YESThe question is about whether management conveys that the cost of serving the next increment of business has become unusually low, meaning additional volume can be delivered with already built and pai...YES Management describes the HPMC segment’s leverage from “additional volume across our asset base” and “utilization increases across our isothermal and conventional forging assets” that already generated “significant incremental margin growth,” with next-generation jet engine sales up 65% and now at 48% of total jet engine sales. They state they are “well positioned both in capability and capacity to continue to benefit from these trends well into the future” after noting the fourth press is coming on stream in a couple of years.
UMH · Q3 2018 → YESThe question is about whether management conveys that the cost of serving the next increment of business has become unusually low, meaning additional volume can be delivered with already built and pai...YES The transcript shows management conveying exactly this situation: the company already owns 3,600 vacant sites (most acquired) plus 6,215 rental homes (93.3% occupied), so the next increment of rental-home business can be served on infrastructure already paid for and in place. They explicitly call the rental program “the most efficient way to fill the vacant sites,” and they are already adding 608 homes this year on track for 800, with Same-Property occupancy rising to 83.2% and expense ratios improving as occupancy climbs.